172 related articles for article (PubMed ID: 23784627)
1. Design and biological characterization of hybrid compounds of curcumin and thalidomide for multiple myeloma.
Liu K; Zhang D; Chojnacki J; Du Y; Fu H; Grant S; Zhang S
Org Biomol Chem; 2013 Aug; 11(29):4757-63. PubMed ID: 23784627
[TBL] [Abstract][Full Text] [Related]
2. Effect and Mechanism of Curcumin on EZH2 - miR-101 Regulatory Feedback Loop in Multiple Myeloma.
Wu C; Ruan T; Liu W; Zhu X; Pan J; Lu W; Yan C; Tao K; Zhang W; Zhang C
Curr Pharm Des; 2018; 24(5):564-575. PubMed ID: 28322158
[TBL] [Abstract][Full Text] [Related]
3. Novel tubulin-polymerization inhibitor derived from thalidomide directly induces apoptosis in human multiple myeloma cells: possible anti-myeloma mechanism of thalidomide.
Iguchi T; Yachide-Noguchi T; Hashimoto Y; Nakazato S; Sagawa M; Ikeda Y; Kizaki M
Int J Mol Med; 2008 Feb; 21(2):163-8. PubMed ID: 18204782
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of new challenging thalidomide analogs as potential anticancer immunomodulatory agents.
El-Zahabi MA; Sakr H; El-Adl K; Zayed M; Abdelraheem AS; Eissa SI; Elkady H; Eissa IH
Bioorg Chem; 2020 Nov; 104():104218. PubMed ID: 32932121
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of novel (E)-N-phenyl-4-(pyridine-acylhydrazone) benzamide derivatives as potential antitumor agents for the treatment of multiple myeloma (MM).
Li XY; Li S; Lu GQ; Wang DP; Liu KL; Qian XH; Xue WH; Meng FH
Bioorg Chem; 2020 Oct; 103():104189. PubMed ID: 32890996
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization and ROS-mediated antitumor effects of palladium(II) complexes of curcuminoids.
Li Y; Gu Z; Zhang C; Li S; Zhang L; Zhou G; Wang S; Zhang J
Eur J Med Chem; 2018 Jan; 144():662-671. PubMed ID: 29289889
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, and Biological Activity of Isosyringolin A.
Kitahata S; Chiba T; Yoshida T; Ri M; Iida S; Matsuda A; Ichikawa S
Org Lett; 2016 May; 18(9):2312-5. PubMed ID: 27123978
[TBL] [Abstract][Full Text] [Related]
8. Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-κB pathways.
Allegra A; Speciale A; Molonia MS; Guglielmo L; Musolino C; Ferlazzo G; Costa G; Saija A; Cimino F
Toxicol In Vitro; 2018 Mar; 47():186-194. PubMed ID: 29223572
[TBL] [Abstract][Full Text] [Related]
9. Asymmetrical meta-methoxylated diarylpentanoids: Rational design, synthesis and anti-cancer evaluation in-vitro.
Leong SW; Chia SL; Abas F; Yusoff K
Eur J Med Chem; 2018 Sep; 157():716-728. PubMed ID: 30138803
[TBL] [Abstract][Full Text] [Related]
10. Discovery of New Monocarbonyl Ligustrazine-Curcumin Hybrids for Intervention of Drug-Sensitive and Drug-Resistant Lung Cancer.
Ai Y; Zhu B; Ren C; Kang F; Li J; Huang Z; Lai Y; Peng S; Ding K; Tian J; Zhang Y
J Med Chem; 2016 Mar; 59(5):1747-60. PubMed ID: 26891099
[TBL] [Abstract][Full Text] [Related]
11. Novel Curcumin Inspired Antineoplastic 1-Sulfonyl-4-Piperidones: Design, Synthesis and Molecular Modeling Studies.
Fawzy NG; Panda SS; Fayad W; El-Manawaty MA; Srour AM; Girgis AS
Anticancer Agents Med Chem; 2019; 19(8):1069-1078. PubMed ID: 30961509
[TBL] [Abstract][Full Text] [Related]
12. Design and linkage optimization of ursane-thalidomide-based PROTACs and identification of their targeted-degradation properties to MDM2 protein.
Qi Z; Yang G; Deng T; Wang J; Zhou H; Popov SA; Shults EE; Wang C
Bioorg Chem; 2021 Jun; 111():104901. PubMed ID: 33878647
[TBL] [Abstract][Full Text] [Related]
13. Synergistic apoptotic effect of arabinoxylan rice bran (MGN-3/Biobran) and curcumin (turmeric) on human multiple myeloma cell line U266 in vitro.
Ghoneum M; Gollapudi S
Neoplasma; 2011; 58(2):118-23. PubMed ID: 21275460
[TBL] [Abstract][Full Text] [Related]
14. [Effect of curcumin on expression of survivin, Bcl-2 and Bax in human multiple myeloma cell line].
Liu B; Bai QX; Chen XQ; Gao GX; Gu HT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):762-6. PubMed ID: 17708799
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of allylated mono-carbonyl analogues of curcumin (MACs) as anti-cancer agents for cholangiocarcinoma.
Qiu C; Hu Y; Wu K; Yang K; Wang N; Ma Y; Zhu H; Zhang Y; Zhou Y; Chen C; Li S; Fu L; Zhang X; Liu Z
Bioorg Med Chem Lett; 2016 Dec; 26(24):5971-5976. PubMed ID: 27825763
[TBL] [Abstract][Full Text] [Related]
16. Photocytotoxic cancer cell-targeting platinum(ii) complexes of glucose-appended curcumin and biotinylated 1,10-phenanthroline.
Upadhyay A; Gautam S; Ramu V; Kondaiah P; Chakravarty AR
Dalton Trans; 2019 Dec; 48(47):17556-17565. PubMed ID: 31748772
[TBL] [Abstract][Full Text] [Related]
17. Curcumin inspired 2-chloro/phenoxy quinoline analogues: Synthesis and biological evaluation as potential anticancer agents.
Sri Ramya PV; Guntuku L; Angapelly S; Karri S; Digwal CS; Babu BN; Naidu VGM; Kamal A
Bioorg Med Chem Lett; 2018 Mar; 28(5):892-898. PubMed ID: 29429834
[TBL] [Abstract][Full Text] [Related]
18. Curcumin Derivatives Verify the Essentiality of ROS Upregulation in Tumor Suppression.
Nakamae I; Morimoto T; Shima H; Shionyu M; Fujiki H; Yoneda-Kato N; Yokoyama T; Kanaya S; Kakiuchi K; Shirai T; Meiyanto E; Kato JY
Molecules; 2019 Nov; 24(22):. PubMed ID: 31717651
[TBL] [Abstract][Full Text] [Related]
19. A novel curcumin derivative which inhibits P-glycoprotein, arrests cell cycle and induces apoptosis in multidrug resistance cells.
Lopes-Rodrigues V; Oliveira A; Correia-da-Silva M; Pinto M; Lima RT; Sousa E; Vasconcelos MH
Bioorg Med Chem; 2017 Jan; 25(2):581-596. PubMed ID: 27908756
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and anticancer evaluation of long-chain alkoxylated mono-carbonyl analogues of curcumin.
Weng Q; Fu L; Chen G; Hui J; Song J; Feng J; Shi D; Cai Y; Ji J; Liang G
Eur J Med Chem; 2015 Oct; 103():44-55. PubMed ID: 26318057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]